• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高脂血症和他汀类药物影响腰椎损伤的神经功能结局。

Hyperlipidemia and statins affect neurological outcome in lumbar spine injury.

作者信息

Chung Wu-Fu, Liu Shih-Wei, Chang Peng-Yuan, Lin Feng-Shu, Chen Li-Fu, Wu Jau-Ching, Chen Yu-Chun, Liu Laura, Huang Wen-Cheng, Cheng Henrich, Lo Su-Shun

机构信息

Department of Emergency Medicine, National Yang-Ming University Hospital, I-Lan 260, Taiwan.

Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei 112, Taiwan.

出版信息

Int J Environ Res Public Health. 2015 Jan 5;12(1):402-13. doi: 10.3390/ijerph120100402.

DOI:10.3390/ijerph120100402
PMID:25568970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4306869/
Abstract

The disabling pathophysiologic effects of lipid and neuroprotective effects of statins have recently been demonstrated for acute spinal cord injuries in animal models. This large scale population-based study aimed to investigate the effect hyperlipidemia and the use of statins in patients with lumbar spine injury. The National Health Insurance Research Database of Taiwan was used to identify patients with lumbar spine injury. A total of 2844 patients were grouped into three: no hyperlipidemia, hyperlipidemia using low-dose of statins (≤90 of the defined daily dosage (DDD)), and severe hyperlipidemia using high-dose of statins (>90 DDD). A Cox multiple regression model was used to compare the incidence rates of disability among the three groups. The results showed that patients with hyperlipidemia appeared a higher risk of permanent disability (adjusted HR = 1.38, p = 0.28). In subgroup analysis, patients with severe hyperlipidemia had a higher risk of disability (adjusted HR = 3.1, p < 0.004), whereas hyperlipidemia using low-dose statins had a similar risk of permanently disability (adjusted HR = 0.83, p = 0.661). Hyperlipidemia adversely affected the neurological outcomes of lumbar spinal injury. Statins may have the potential to reverse this higher risk of disability. However, this beneficiary effect of statins only existed in patients using a lower dose (≤90 DDD).

摘要

脂质的致残病理生理效应和他汀类药物的神经保护作用最近在动物模型的急性脊髓损伤中得到了证实。这项基于大规模人群的研究旨在调查高脂血症和他汀类药物的使用对腰椎损伤患者的影响。台湾国民健康保险研究数据库被用于识别腰椎损伤患者。总共2844名患者被分为三组:无高脂血症、使用低剂量他汀类药物(≤规定日剂量(DDD)的90)的高脂血症患者,以及使用高剂量他汀类药物(>90 DDD)的严重高脂血症患者。使用Cox多元回归模型比较三组之间的残疾发生率。结果显示,高脂血症患者出现永久性残疾的风险更高(调整后的风险比=1.38,p=0.28)。在亚组分析中,严重高脂血症患者的残疾风险更高(调整后的风险比=3.1,p<0.004),而使用低剂量他汀类药物的高脂血症患者出现永久性残疾的风险相似(调整后的风险比=0.83,p=0.661)。高脂血症对腰椎损伤的神经学结果产生不利影响。他汀类药物可能有逆转这种较高残疾风险的潜力。然而,他汀类药物的这种有益作用仅存在于使用较低剂量(≤90 DDD)的患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8209/4306869/1f1e0320fdc8/ijerph-12-00402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8209/4306869/879a87e3da01/ijerph-12-00402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8209/4306869/88018273e990/ijerph-12-00402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8209/4306869/1f1e0320fdc8/ijerph-12-00402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8209/4306869/879a87e3da01/ijerph-12-00402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8209/4306869/88018273e990/ijerph-12-00402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8209/4306869/1f1e0320fdc8/ijerph-12-00402-g003.jpg

相似文献

1
Hyperlipidemia and statins affect neurological outcome in lumbar spine injury.高脂血症和他汀类药物影响腰椎损伤的神经功能结局。
Int J Environ Res Public Health. 2015 Jan 5;12(1):402-13. doi: 10.3390/ijerph120100402.
2
Increased risk of new-onset depression in patients with traumatic brain injury and hyperlipidemia: the important role of statin medications.创伤性脑损伤合并高脂血症患者新发抑郁症风险增加:他汀类药物的重要作用。
J Clin Psychiatry. 2016 Apr;77(4):505-11. doi: 10.4088/JCP.14m09749.
3
Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study.降脂药物的使用与高血脂患者慢性阻塞性肺疾病的关系:一项基于人群的回顾性队列研究。
Int J Chron Obstruct Pulmon Dis. 2020 Oct 20;15:2573-2581. doi: 10.2147/COPD.S267017. eCollection 2020.
4
The effect of statins on the occurrence of peptic ulcer.他汀类药物对消化性溃疡发生的影响。
Eur J Intern Med. 2015 Nov;26(9):731-5. doi: 10.1016/j.ejim.2015.07.015. Epub 2015 Jul 27.
5
Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.他汀类药物可降低系统性红斑狼疮高脂血症患者的死亡率和发病率:一项基于全国人群的队列研究。
Atherosclerosis. 2015 Nov;243(1):11-8. doi: 10.1016/j.atherosclerosis.2015.08.030. Epub 2015 Aug 28.
6
Adherence to Statins Use and Risk of Dementia among Patients with Diabetes and Comorbid Hyperlipidemia.糖尿病合并高脂血症患者他汀类药物的依从性与痴呆风险。
Inquiry. 2021 Jan-Dec;58:469580211019201. doi: 10.1177/00469580211019201.
7
Hyperlipidemia and statins use for the risk of new-onset anxiety/depression in patients with head and neck cancer: A population-based study.高脂血症及他汀类药物使用与头颈癌患者新发焦虑/抑郁风险:一项基于人群的研究。
PLoS One. 2017 Mar 31;12(3):e0174574. doi: 10.1371/journal.pone.0174574. eCollection 2017.
8
Hyperlipidemia, statin use and the risk of developing depression: a nationwide retrospective cohort study.高脂血症、他汀类药物使用与患抑郁症风险:一项全国性回顾性队列研究。
Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):497-501. doi: 10.1016/j.genhosppsych.2014.05.008. Epub 2014 May 17.
9
Association between antihyperlipidemic agents and the risk of chronic periodontitis in patients with hyperlipidemia: A population-based retrospective cohort study in Taiwan.降脂药物与高血脂患者慢性牙周炎风险的相关性:基于人群的台湾回顾性队列研究。
J Periodontol. 2024 May;95(5):483-493. doi: 10.1002/JPER.23-0166. Epub 2023 Oct 4.
10
Hyperlipidemia and Statins Use for the Risk of New Diagnosed Sarcopenia in Patients with Chronic Kidney: A Population-Based Study.高脂血症和他汀类药物用于慢性肾脏病患者新发肌少症的风险:一项基于人群的研究。
Int J Environ Res Public Health. 2020 Feb 26;17(5):1494. doi: 10.3390/ijerph17051494.

引用本文的文献

1
Lipid metabolic disorders and their impact on cartilage endplate and nucleus pulposus function in intervertebral disk degeneration.脂质代谢紊乱及其对椎间盘退变中软骨终板和髓核功能的影响。
Front Nutr. 2025 Mar 10;12:1533264. doi: 10.3389/fnut.2025.1533264. eCollection 2025.
2
Delayed atorvastatin delivery promotes recovery after experimental spinal cord injury.实验性脊髓损伤后,阿托伐他汀延迟释放促进恢复。
Neurotherapeutics. 2025 Mar;22(2):e00517. doi: 10.1016/j.neurot.2024.e00517. Epub 2025 Jan 4.
3
Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: a drug-targeted mendelian randomized study and cross-sectional observation.

本文引用的文献

1
Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington's disease like symptoms and related cognitive dysfunction in rats.罗非昔布和他汀类药物协同神经保护作用对丙二酸诱导的大鼠亨廷顿病样症状及相关认知功能障碍的作用。
Eur J Pharmacol. 2013 Jun 5;709(1-3):1-12. doi: 10.1016/j.ejphar.2013.03.042. Epub 2013 Apr 3.
2
Simvastatin ameliorates cauda equina compression injury in a rat model of lumbar spinal stenosis.辛伐他汀改善腰椎管狭窄症大鼠模型的马尾压迫损伤。
J Neuroimmune Pharmacol. 2013 Mar;8(1):274-86. doi: 10.1007/s11481-012-9419-3. Epub 2012 Nov 28.
3
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
降脂药物与椎间盘退变、坐骨神经痛和腰痛的关联:一项药物靶向孟德尔随机研究和横断面观察。
Lipids Health Dis. 2024 Oct 2;23(1):327. doi: 10.1186/s12944-024-02311-w.
4
The role of immune cells and associated immunological factors in the immune response to spinal cord injury.免疫细胞及相关免疫因子在脊髓损伤免疫反应中的作用。
Front Immunol. 2023 Jan 5;13:1070540. doi: 10.3389/fimmu.2022.1070540. eCollection 2022.
他汀类药物的使用与帕金森病风险:观察性研究的荟萃分析。
J Neurol. 2013 Jan;260(1):158-65. doi: 10.1007/s00415-012-6606-3. Epub 2012 Jul 21.
4
Simvastatin mobilizes bone marrow stromal cells migrating to injured areas and promotes functional recovery after spinal cord injury in the rat.辛伐他汀动员骨髓基质细胞迁移至损伤部位,并促进大鼠脊髓损伤后的功能恢复。
Neurosci Lett. 2012 Jul 19;521(2):136-41. doi: 10.1016/j.neulet.2012.05.071. Epub 2012 Jun 5.
5
Spinal cord trauma and the molecular point of no return.脊髓创伤与分子不可逆转点。
Mol Neurodegener. 2012 Feb 8;7:6. doi: 10.1186/1750-1326-7-6.
6
Oxidative stress in spinal cord injury and antioxidant-based intervention.脊髓损伤中的氧化应激和基于抗氧化剂的干预。
Spinal Cord. 2012 Apr;50(4):264-74. doi: 10.1038/sc.2011.111. Epub 2011 Oct 11.
7
Reduction of spinal cord ischemia/reperfusion injury with simvastatin in rats.辛伐他汀减轻大鼠脊髓缺血/再灌注损伤。
Anesth Analg. 2011 Sep;113(3):565-71. doi: 10.1213/ANE.0b013e318224ac35. Epub 2011 Jun 16.
8
Statins and neuroprotection: a prescription to move the field forward.他汀类药物与神经保护:推动该领域前进的处方。
Ann N Y Acad Sci. 2010 Jun;1199:69-76. doi: 10.1111/j.1749-6632.2009.05359.x.
9
Neuroprotective effect of atorvastatin in an experimental model of nerve crush injury.阿托伐他汀在神经挤压伤实验模型中的神经保护作用。
Neurosurgery. 2010 Aug;67(2):376-88; discussion 388-9. doi: 10.1227/01.NEU.0000371729.47895.A0.
10
Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.瑞舒伐他汀预处理通过调节一氧化氮合酶表达对大鼠脊髓缺血提供神经保护作用。
Brain Res. 2010 Jul 30;1346:251-61. doi: 10.1016/j.brainres.2010.05.068. Epub 2010 May 31.